0001415889-23-015129.txt : 20231114 0001415889-23-015129.hdr.sgml : 20231114 20231114205936 ACCESSION NUMBER: 0001415889-23-015129 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231103 FILED AS OF DATE: 20231114 DATE AS OF CHANGE: 20231114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schwartz Jonathan David CENTRAL INDEX KEY: 0001726398 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37888 FILM NUMBER: 231408850 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET STREET 2: SUITE 1040 CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tabula Rasa HealthCare, Inc. CENTRAL INDEX KEY: 0001651561 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 465726437 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 228 STRAWBRIDGE DRIVE STREET 2: SUITE 100 CITY: MOORESTOWN STATE: NJ ZIP: 08057 BUSINESS PHONE: 866-648-2767 MAIL ADDRESS: STREET 1: 228 STRAWBRIDGE DRIVE STREET 2: SUITE 100 CITY: MOORESTOWN STATE: NJ ZIP: 08057 4 1 form4-11152023_011129.xml X0508 4 2023-11-03 1 0001651561 Tabula Rasa HealthCare, Inc. TRHC 0001726398 Schwartz Jonathan David 228 STRAWBRIDGE DRIVE SUITE 100 MOORESTOWN NJ 08057 true false false false 0 Common Stock 2023-11-03 4 D 0 17582 D 60806 D Common Stock 2023-11-03 4 D 0 60806 D 0 D Upon the consummation of the merger (the "Merger") contemplated by that certain Agreement and Plan of Merger, by and among Tabula Rasa HealthCare, Inc. (the "Company"), Locke Buyer, LLC and Locke Merger Sub, Inc., dated August 5, 2023 (the "Merger Agreement"), 17,582 shares of common stock of the Company ("Common Stock") were converted into the right to receive a cash payment of $184,611, representing the product obtained by multiplying (x) the number of shares of Common Stock owned by the reporting person, by (y) the offer price ($10.50). Upon the consummation of the Merger, pursuant to the Merger Agreement, 60,806 unvested restricted stock awards ("RSAs") were cancelled and converted into the right to receive a cash payment of $638,463, representing the product obtained by multiplying (x) the aggregate number of shares of Common Stock underlying the RSAs, by (y) the offer price ($10.50). /s/ Brian W. Adams, by Power of Attorney 2023-11-14